Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04931368
Title OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma (OptiMATe)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Klinikum Stuttgart

central nervous system lymphoma


Cytarabine + Methotrexate + Rituximab + Thiotepa

Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Klinikum Stuttgart Recruiting Stuttgart Baden-Württemberg 70174 Germany Details
*Shaded cells indicate that there was no data available from for the field